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Abstract: 
Objective: The objective of this research is to evaluate and contrast the medical treatment and MVA (Manual 
Vacuum Aspiration) for managing the miscarriage in the 1st trimester.  
Material and Methods: This comparative research was conducted at Sir Ganga Ram Hospital, Lahore (August 
2017 to March 2018). This research consists of a total of 92 cases of patients having a gestation age of less than 
twelve (12) weeks of missed abortion in the first trimester. Two groups were made of the patients: group A was 
treated with MVA whereas group B was treated medically and their effectiveness was evaluated. 
Results: The patients’ mean age was (29.77 ± 6.786) years in which group A patients’ mean age was (30.61 ± 
6.754) years while group B patients’ mean age was (28.93 ± 6.787) years. The gestational mean age was (5.87 ± 
3.592) weeks in which group A gestational mean age was (6.09 ± 3.699) weeks while group B gestational mean age 
was (5.65 ± 3.510) weeks. In group A patients, the effectiveness of treatment was 91.30% (42 out of 46 patients) 
while in the group B patients, the effectiveness of the treatment was 69.57% (32 out of 46 patients). The rate of 
effectiveness of cure for group A was considerably greater than Group B i.e., 91.30% as compared to 69.57%, 
having (p=0.009). 
Conclusion: The outcome of this research proved that MVA is a far more useful modality of treatment than medical 
treatment i.e., misoprostol intravaginally, as the rate of effectiveness of cure was considerably greater for the group 
of MVA than the group which was treated medically and it was especially true in the group of patients with older 
ages.  
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INTRODUCTION: 
The uterus is, conventionally, evacuated surgically in 
the miscarriage of first trimester [1, 2]. This 
technique was started in the 2nd half of the 19th 
century after the invention of sharp curettes [3]. Even 
though it was adopted for reducing the danger of 
haemorrhage and infection, many other 
complications like endometritis, perforation of the 
uterus and cervical trauma were reported to be linked 
with it [4]. Moreover, reduced fertility, uterine 
synechia, pelvic pain and tubal damage are the 
complications of long term [4]. At present, by the 
virtue of misoprostol or prostaglandin analogue, the 
termination of the miscarriage of the first trimester is 
medically considered as an effective and safe choice 
[5]. Nevertheless, it has its own complications like 
pain, the requirement of emergency evacuation 
surgically, more requirement of analgesic and more 
induction abortion time [3, 5]. The other method of 
treating the miscarriage of the first trimester is MVA 
(Manual Vacuum Aspiration). When used by experts, 
the MVA method is cost effective and a very safe 
method. No doubt there has been much advancement 
in science, especially in the medical field, but still, 
10% – 13% complications concerning abortion exist 
in the developing countries [6]. Most of the patients 
belong to the poor class. The effectiveness of both 
the methods will be evaluated for ascertaining the 
better way of managing the miscarriage of 1st 
trimester in the patients.  
 
Complete Abortion: The cavity of uterine isempty 
on pelvic USG. 
Manual Vacuum Aspiration (MVA): It is 
performed through a cannula of flexible "Ipas Easy 
Grip" attached to a 60 ml syringe(aspirator), having a 
valve mechanism of double locking. 
Medical Management: 800μg misoprostol was 
given intravaginally. 
The first Trimester Missed Abortion: The patients 
were judged by the followings: 
1. The symptom of pregnancy like vomiting, morning 
sickness, nausea. 
2. Through bimanual pelvic examination, the uterus 
of small size as related to the period of pregnancy.  
3. On ultrasonography, the absence of cardiac 
motion. 
 
MATERIAL AND METHODS: 
This comparative research was conducted at Sir 
Ganga Ram Hospital, Lahore (August 2017 to March 
2018). We included all those patients of a missed 
miscarriage of 1st trimester having gestation age of 
not more than twelve (12) weeks, identified through 
ultrasonography to have a gestational sac not more 
than 25 mm diameter without any cardiac activity of 
the fetal. The ages of the patients were 18 - 40 years. 
All were included whether grand multipara, multipara 
or primary para. Whereas, we did not include patients 
who were hypersensitive to the use of misoprostol, 
patients who were having less than twelve weeks 
gestation age, patients having ectopic molar or 
pregnancy, patients having a septic abortion and 
patients having cesarean section previously. A total 
of 92 patients of a missed miscarriage of 1st trimester 
was made a part of this research after written 
approval of the institution and each of the patients. 
They were randomly allotted Group “A” or Group 
“B”. In the patients of Group “A”, MVA was carried 
out while the Group “B” patients were given 
Misoprostolintra-virginally. 
 
To the patients of Group – A, tab Brufen, tab valium 
and Doxycycline 100 mg (prophylactic antibiotic) 
were given an hour before starting the process. 
Paracervical block as local analgesia was 
administered to the patients. MVA was used to 
evaluate the uterine cavity and the evacuation 
efficacy was confirmed as red or pink foam minus 
RPOC’s passing in the cannula. If the conception 
products continued to pass instead of changing 
cannula even four times, it was diagnosed that the 
evacuation was incomplete and it needed another 
technique for evacuating uterus. The 2nd group 
patients were given misoprostol intravaginally. Every 
patient was given 800 μg misoprostol with 
hydroxyethyl gel of 2.5 ml per vagina. Misoprostol 
was in the white colour powder form of Cytotec 
tablets made by Searle, USA. Then it was combined 
with sterile hydroxyethyl gel of 2.5 ml made by 
GlaxoSmithKline, Pakistan. Then a disposable 
syringe of 5ml, with its needle removed, was filled 
with it. The mixture is injected in the vaginal fornix 
and the counting of time started. USG of Pelvic was 
carried out and if there had been RPOCs then at the 
interval of six hours at the most 2 doses of 400μg of 
misoprostol were given. After the completion of three 
doses, eighteen hours later, the end result is 
evaluated. The effectiveness of both the groups along 
with the demographic information of the patients was 
noted on a pro forma which was already designed. 
For analysis of the data statistically, it was checked 
by SPSS. The variables which were quantitative as 
gestational age and the age of the patient were shown 
as mean and standard deviation whereas variables 
which were qualitative variables as parity and 
efficacy were shown in the form of percentages and 
frequencies. For comparing the efficacy of both the 
groups, we utilized the chi-square test. The 
classification was carried out for parity, the age of 
gestation and the age of the patient. After 
classification, for knowing significance level, the chi-
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square test was utilized and the significant value 
statistically was considered as P≤ 0.05. 
 
RESULTS: 
The total number of patients chosen for this research 
was 92. The patients’ mean age was (29.77 ± 6.786) 
years, while group A patients’ mean age was (30.61 ± 
6.754) years and group B patients’ mean age was 
(28.93 ± 6.787) years. The mean of age of gestation 
was (5.87 ± 3.592) weeks while the mean age of 
gestation of group A patients was (6.09 ± 3.699) 
weeks and the mean of age of gestation of group B 
patients was (5.65 ± 3.510) weeks. 
 
In group A, the effectiveness of treatment was 
91.30% (42 patients out of 46) while in group B the 
effectiveness of the treatment was 69.57% (32 
patients out of 46) having a value of P=0.009. The 
effectiveness of treatment was 85.71% (18 patients) 
in group A patients whereas it was 77.78% (21 
patients) in the group B patients for the ages from 20 
to 30 years, but this difference of effectiveness was 
insignificant statistically. The effectiveness of 
treatment was 96% (24 patients) in group A whereas 
it was 57.89% (11 patients) in the group B patients 
for the ages from 31 to 40 years and the difference of 
effectiveness was significant statistically. The 
effectiveness of treatment was 84.62% (22 patients) 
in group A, whereas it was 68.97% (20 patients) in 
the group B patients for the age of gestation from 01 
to 06 weeks and the difference of effectiveness was 
insignificant statistically. The effectiveness of 
treatment was 100% (20 patients) in group A, 
whereas it was 70.59% (12 patients) in the group B 
patients for the age of gestation from 07 to 12 weeks 
and the difference of effectiveness was significant 
statistically.   
 
The effectiveness of treatment was 100% (8 patients) 
in group A, whereas it was 68.75% (11 patients) in 
the group B patients for the primary paras but the 
difference of effectiveness was not significant 
statistically. The effectiveness of treatment was 
78.95% (15 patients) in group A, whereas it was 80% 
(12 patients) in the group B patients for the 
multiparas but the difference of effectiveness was 
significant statistically. The effectiveness of 
treatment was 100% (19 patients) in group A, 
whereas it was 60% (9 patients) in the group B 
patients for the grand multiparas and the difference of 
effectiveness was significant statistically.  
 
DISCUSSION: 
The aim of this research is to evaluate and contrast 
the medical treatment and MVA (Manual Vacuum 
Aspiration) for managing the miscarriage in the 1st 
trimester. The patients’ mean age was (29.77 ± 
6.786) years, while group A patients’ mean age was 
(30.61 ± 6.754) years and group B patients’ mean age 
was (28.93 ± 6.787) years. The mean of age of 
gestation was (5.87 ± 3.592) weeks while the mean 
age of gestation of group A patients was (6.09 ± 
3.699) weeks and the mean of age of gestation of 
group B patients was (5.65 ± 3.510) weeks. 
 
The rate of effectiveness of treatment was higher 
significantly for the group A which was treated with 
MVA in comparison to the group B which was 
treated by medical management i.e., in group A, the 
effectiveness of treatment was 91.30% (42 patients 
out of a total of 46) while in group B the 
effectiveness of the treatment was 69.57% (32 
patients out of a total of 46) having value of P= 
0.009.  
 
Bique have observed, while comparing the 
effectiveness of treatment of missed miscarriage with 
MVA and misoprostol, that MVA rate of treatment 
success was 100% and that of misoprostol was 91% 
with P=0.002 after the treatment, 7 days later, for 
follow-up [7]. His research recommended MVA for 
the treatment of missed miscarriage of the first 
trimester. MVA was reported to be more effective, 
safe and faster as compared to treatment with 
misoprostol for the age of gestation from 09 to 12 
weeks [8]. Tasnim N conducted a study in which up 
to 89.6% of patients were treated successfully 
through the MVA method [9]. Hamlin J conducted 
research which proved that the rate of success of 
treatment with MVA was 95.2% [10]. Edwards S 
conducted a study in which up to 98% of patients 
were treated successfully through the MVA method 
[11]. The rate of success of the MVA method was 
97.7% in the research of Ansari R [12]. The results of 
all these researches confirm the findings we have 
discovered in our study. 
 
The rate of success, for the treatment of missed 
miscarriage through the administration of misoprostol 
vaginally, sublingually or orally, has been 25% – 
97% in various researches. This difference among the 
researches may have been due to the various standard 
of the rate of success, different ways of administering 
and the different routines of using misoprostol [13].        
The research of Shuaib AA, in which misoprostol 
was administered intravaginally to 52 female 
patients, shows a 80.7% success rate of expelling the 
products of conception [13]. The research of Shankar 
M also proves that because of the administration of 
misoprostol, 77.3% of female patients had complete 
successful evacuation medically [14]. It was also 
proved by Shah N study that because of the use of 
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misoprostol intravaginally, the success rate for 
successful evacuation was 48% [15]. These 
conclusions are all in conformity with the results of 
our research. The patients’ mean age, in our research, 
was (29.77 ± 6.786) years, while group A patients’ 
mean age was (30.61 ± 6.754) years and group B 
patients’ mean age was (28.93 ± 6.787) years. The 
mean age, as well as the mean of the age of gestation, 
can be compared with the Ghazvani research (2014) 
[16].  
 
CONCLUSION: 
This research proves that MVA is a far better 
treatment for the patients of a missed miscarriage of 
1st trimester in comparison to the medically managed 
misoprostol treatment intravaginally. The 
effectiveness rate has been higher significantly for 
the group of MVA patients in comparison to the 
group which was treated medically. The group of 
MVA treatment patients’ effectiveness rate was also 
highly significantly in comparison with the group 
which was treated medically through misoprostol.  
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